human
respiratori
syncyti
viru
hrsv
frequent
caus
acut
respiratori
infect
ari
especi
children
upper
hrsv
infect
spread
lower
respiratori
tree
extent
gener
consid
proport
sever
diseas
collin
crow
advent
highli
sensit
molecular
diagnost
method
report
multipl
respiratori
virus
sampl
becom
increasingli
frequent
greensil
et
al
wolf
et
al
et
al
gagliardi
et
al
howev
implic
simultan
detect
respiratori
virus
children
diseas
fulli
clarifi
sempl
et
al
et
al
vast
major
clinic
studi
concern
question
attribut
nucleic
acid
detect
attempt
distinguish
current
hrsv
replic
prolong
shed
remnant
rna
previou
hrsv
infect
sempl
et
al
martin
et
al
present
studi
done
tri
shed
light
whether
common
respiratori
virus
associ
increas
sever
ari
episod
confirm
shed
viabl
hrsv
recover
respiratori
secret
cell
cultur
studi
done
nasopharyng
aspir
submit
virolog
laboratori
hrsv
screen
year
sampl
collect
children
year
age
ari
seen
univers
paulo
hospit
santa
lydia
commun
hospit
citi
preto
brazil
januari
decemb
nasopharyng
aspir
obtain
previous
describ
procedur
cintra
et
al
sent
laboratori
less
hr
screen
hrsv
indirect
immunofluoresc
virolog
laboratori
sampl
suction
trap
wash
small
amount
pb
complet
total
volum
approxim
ml
sampl
treat
antibioticantimycot
penicillin
streptomycin
amphothericin
b
ciprofloxacin
hr
distribut
two
aliquot
mix
life
technolog
carlsbad
ca
anoth
two
backup
aliquot
mix
vtm
vtm
consist
minim
essenti
medium
eagl
salt
plu
fetal
bovin
serum
fb
glycerol
solut
life
technolog
backup
aliquot
store
use
remaind
npa
use
prepar
glass
slide
hrsv
screen
use
monoclon
antibodi
mab
millipor
bilerica
dilut
pb
follow
wash
three
time
pb
detect
alexa
donkey
antimous
igg
life
technolog
pb
min
screen
nasopharyng
aspir
hrsv
total
rna
extract
one
aliquot
use
manufactur
protocol
revers
transcript
carri
revers
transcriptas
promega
madison
wi
prime
random
hexam
follow
manufactur
protocol
first
round
pcr
done
primer
fv
gab
second
round
carri
format
ad
primer
tabl
pcr
round
done
taq
biotool
madrid
spain
use
cycl
min
min
min
final
extens
period
min
amplicon
size
pb
pb
hrsv
amplicon
sequenc
bigdy
termin
cycl
sequenc
kit
life
technolog
abi
prism
dna
sequenc
prior
sampl
inocul
monolay
incub
min
pb
ph
life
technolog
vtm
backup
aliquot
inocul
duplic
monolay
cell
plate
mem
supplement
fb
incub
absorpt
hr
room
temperatur
replenish
fresh
mem
fb
incub
cytopath
effect
cpe
develop
cell
remov
scrape
spot
onto
glass
slide
fix
cold
aceton
confirm
hrsv
isol
cell
cultur
without
discern
cpe
harvest
day
incub
blind
passag
onto
fresh
monolay
cell
line
addit
day
observ
cpe
confirm
hrsv
sampl
posit
hrsv
isol
cell
cultur
test
pcr
human
metapneumoviru
hmpv
picornavirus
human
human
coronavirus
hcov
human
parainfluenzavirus
hpiv
human
influenza
virus
flu
b
human
adenoviru
hadv
human
bocaviru
hbov
tabl
rna
extract
describ
hrsv
revers
transcript
carri
revers
transcriptas
promega
manufactur
protocol
prime
random
hexam
except
hcov
primer
use
tabl
test
dna
virus
fraction
obtain
extract
protocol
use
dna
purif
use
dna
purif
kit
promega
individu
pcr
assay
done
hmpv
picornavirus
flu
b
hadv
hbov
specif
primer
tabl
picornaviru
pcr
product
test
probe
ggccgccaacgcagcc
specif
enterovirus
ev
hybrid
assay
follow
previous
publish
procedur
et
al
picornaviru
amplicon
found
neg
ev
assay
sequenc
confirm
posit
human
rhinoviru
hrv
neg
posit
control
includ
pcr
assay
pcr
done
intern
control
presenc
extract
dna
test
sampl
amplif
pcr
product
visual
agaros
gel
stain
ethidium
bromid
pcr
prepar
product
analysi
done
separ
room
segreg
materi
instrument
patient
record
analyz
check
symptomssign
requir
oxygenrespiratori
support
compar
assess
diseas
sever
use
index
clinic
sever
ic
numer
score
adapt
walsh
et
al
base
presenc
wheez
requir
hospit
oxygen
therapi
requir
posit
airway
pressur
ic
obtain
attribut
one
point
presenc
wheez
requir
hospit
length
hospit
stay
longer
day
requir
use
day
total
five
point
two
addit
point
given
patient
requir
ventil
support
posit
airway
pressur
thu
result
maximum
ic
sever
diseas
tabl
ii
clinic
data
analyz
test
look
associ
qualit
quantit
variabl
continu
variabl
analyz
test
applic
estim
logist
regress
use
procedur
proc
logist
softwar
statist
signific
consid
total
nasopharyng
aspir
collect
children
boy
median
age
month
rang
day
month
screen
hrsv
immedi
later
percent
sampl
outpati
remain
inpati
admit
pediatr
gener
ward
pediatr
intens
care
pediatr
infecti
diseas
unit
hrsv
detect
aspir
posit
indirect
hsrv
posit
occur
februari
novemb
peak
activ
april
june
correspond
autumn
fig
sampl
came
children
boy
median
age
month
rang
day
month
remain
sampl
collect
patient
boy
median
age
month
rang
day
month
sampl
came
pediatr
gener
infecti
diseas
ward
pediatr
intens
care
unit
outpati
pediatr
clinic
clinic
featur
compar
children
sampl
neg
hrsv
tabl
iii
median
ic
children
oppos
ic
group
keep
sever
diseas
occur
oppos
patient
p
also
patient
requir
oxygen
p
mechan
ventil
p
often
one
tabl
iii
sneez
p
nasal
obstruct
p
occur
frequent
children
tabl
iii
therefor
data
confirm
ari
episod
clinic
sever
one
order
restrict
evalu
clinic
featur
ari
episod
associ
current
hrsv
replic
primari
isol
hrsv
attempt
nasopharyng
aspir
backup
aliquot
store
hrsv
isol
cell
sampl
viabl
hrsv
shed
distribut
march
septemb
period
slightli
narrow
overal
hrsv
circul
fig
gender
distribut
boy
median
age
month
rang
day
month
similar
patient
shed
viabl
hrsv
posit
hrsv
without
recoveri
viabl
viru
patient
shed
viabl
hrsv
frequent
outpati
includ
also
inpati
gener
pediatr
intens
care
unit
infecti
diseas
ward
clinic
demograph
featur
significantli
differ
patient
shed
viabl
hrsv
posit
hrsv
without
shed
viabl
viru
tabl
iii
addit
distribut
patient
posit
hrsv
shed
viabl
hrsv
significantli
differ
overal
distribut
sampl
per
origin
accord
hospit
ward
assess
whether
diseas
sever
patient
shed
viabl
hrsv
differ
respiratori
virus
simultan
detect
pcr
nasopharyng
aspir
yield
hrsv
isol
cell
test
pcr
respiratori
virus
sampl
neg
test
virus
wherea
yield
detect
least
one
addit
respiratori
viru
sampl
respiratori
virus
follow
monthli
distribut
sampl
posit
hrsv
fig
gender
ratio
boy
median
age
month
rang
day
month
also
similar
overal
patient
recoveri
viabl
hrsv
associ
detect
viru
nucleic
acid
frequent
secret
outpati
follow
inpati
gener
intens
care
infecti
diseas
pediatr
ward
aspir
contain
viabl
hrsv
simultan
nucleic
acid
virus
one
viru
two
virus
three
virus
four
virus
addit
hrsv
respiratori
virus
detect
simultan
hrsv
hadv
picornavirus
ev
hrv
hbov
hmpv
tabl
iv
signific
differ
demograph
clinic
featur
observ
patient
shed
viabl
hrsv
sampl
viabl
hrsv
plu
one
sampl
two
sampl
three
sampl
four
sampl
virus
data
shown
patient
whose
secret
viabl
hrsv
detect
along
nucleic
acid
four
addit
respiratori
virus
old
girl
syndrom
bronchiol
obliteran
reflux
ic
hospit
day
receiv
mechan
ventil
remark
nasopharyng
aspir
collect
admiss
neg
test
virus
sampl
yield
four
virus
pcr
addit
recoveri
hrsv
cell
cultur
collect
month
hospit
indic
nosocomi
transmiss
detect
virus
clinic
featur
also
compar
among
group
patient
shed
viabl
hrsv
alon
sampl
addit
hadv
sampl
picornavirus
sampl
hrv
sampl
ev
sampl
hbov
sampl
hmpv
sampl
tabl
v
hadv
detect
pcr
associ
recoveri
viabl
hrsv
sampl
interestingli
signific
differ
clinic
featur
patient
patient
replic
hrsv
absenc
hadv
detect
compar
patient
exclus
viabl
hrsv
detect
tabl
v
therefor
although
hadv
frequent
directli
associ
obviou
increas
diseas
sever
comparison
children
diseas
picornaviru
nucleic
acid
detect
hrv
ev
nasopharyng
aspir
children
excret
viabl
hrsv
comparison
clinic
data
patient
shed
exclus
viabl
hrsv
without
hrv
show
hrv
associ
higher
frequenc
coryza
patient
diseas
p
tabl
v
patient
ev
clinic
featur
compar
excret
viabl
hrsv
hrsv
plu
signific
differ
observ
clinic
find
patient
viabl
hrsv
ev
howev
noteworthi
none
patient
ev
requir
mechan
ventil
oppos
one
tabl
v
third
frequent
viru
detect
pcr
nasopharyng
aspir
patient
hrsv
diseas
hbov
detect
children
posit
hbov
addit
viabl
hrsv
older
median
age
month
exclus
viabl
hrsv
median
age
month
clinic
featur
differ
among
group
patient
exclus
viabl
hrsv
hbov
associ
hrsv
without
hbov
tabl
v
clinic
find
also
significantli
differ
patient
viabl
hrsv
hmpv
tabl
v
advent
clinic
applic
rapid
antigen
detect
assay
hrsv
primari
isol
agent
cell
cultur
becom
restrict
research
laboratori
detect
respiratori
viru
antigen
nucleic
acid
facilit
studi
multipl
agent
world
confirm
hrsv
frequent
agent
yet
often
detect
simultan
respiratori
virus
collin
crow
sli
jone
martin
et
al
sever
studi
compar
sever
respiratori
ill
patient
whose
secret
posit
posit
pcr
respiratori
virus
concurr
hrsv
report
signific
differ
canducci
et
al
nascimento
et
al
de
pauli
et
al
howev
detect
hrsv
nucleic
acid
respiratori
secret
regard
firm
evid
current
ill
sinc
could
result
presenc
molecular
remnant
previou
infect
franz
et
al
therefor
present
studi
done
reassess
relev
respiratori
virus
secret
collect
ari
patient
current
harbor
replic
hrsv
whose
viabil
confirm
viru
recoveri
cell
cultur
studi
done
sampl
collect
children
younger
year
patient
detect
diagnost
method
diseas
significantli
sever
neg
hrsv
thu
reaffirm
hrsv
import
pathogen
patient
higher
clinic
sever
score
requir
oxygen
mechan
respiratori
support
thu
reiter
ill
impact
strongli
healthcar
resourc
clinic
featur
significantli
differ
patient
excret
viabl
hrsv
shed
hrsv
nucleic
acid
detect
find
indic
shed
hrsv
rna
practic
marker
current
replic
agent
support
detect
routin
hrsv
clinic
diagnosi
frequenc
hrsv
primari
recoveri
cell
cultur
would
probabl
higher
monolay
inocul
freshli
collect
rather
frozen
specimen
due
reduc
virion
stabil
upon
howev
primari
hrsv
isol
fresh
sampl
labor
intens
rare
done
routin
basi
especi
health
care
facil
develop
countri
moreov
long
turnaround
time
would
like
make
impract
acut
situat
rapid
test
crucial
nevertheless
prospect
studi
may
requir
ascertain
whether
fresh
specimen
inocul
would
better
marker
hrsv
current
infect
remark
three
quarter
patient
shed
viabl
hrsv
therefor
like
ill
also
shed
nucleic
acid
respiratori
virus
frequent
two
suggest
signific
proport
children
ill
also
true
virus
highli
sensit
assay
enabl
trace
amount
viral
nucleic
acid
includ
possibl
vestig
past
infect
authent
two
replic
respiratori
virus
may
also
occur
frequenc
arruda
et
al
studi
base
test
marker
activ
replic
respiratori
virus
requir
establish
proport
true
viral
patient
shed
viabl
hrsv
studi
sever
respiratori
ill
significantli
differ
among
patient
viabl
hrsv
one
two
three
addit
virus
agreement
studi
done
sampl
posit
hrsv
canducci
et
al
nascimento
et
al
de
pauli
et
al
effect
detect
hadv
hrv
hev
hbov
hmpv
diseas
sever
phenotyp
also
evalu
except
higher
frequenc
coryza
found
patient
shed
viabl
hrsv
also
hrv
signific
differ
diseas
phenotyp
note
among
hrsv
patient
group
specif
virus
coryza
frequent
bothersom
symptom
hrv
infect
interest
coryza
note
children
shed
viabl
hrsv
also
hrv
detect
suggest
hrv
associ
actual
concurr
hrv
replic
upper
respiratori
tract
children
hrsv
diseas
concurr
detect
hadv
hbov
dna
patient
shed
viabl
hrsv
could
explain
propens
virus
detect
prolong
period
kalu
et
al
et
al
howev
nucleic
acid
respiratori
virus
secret
along
viabl
replic
hrsv
easi
ascrib
persist
without
test
marker
activ
replic
specif
viru
attempt
present
studi
develop
trustworthi
viru
assay
hamper
rna
yield
cdna
origin
either
rna
strand
even
absenc
exogen
ad
primer
boncristiani
et
al
although
children
whose
respiratori
sampl
test
studi
acut
respiratori
infect
may
nosocomi
infect
one
particular
girl
neg
sampl
collect
admiss
month
later
anoth
sampl
submit
test
posit
viabl
hrsv
evidenc
isol
cell
cultur
four
addit
respiratori
virus
pcr
typic
exampl
nosocomi
infect
respiratori
virus
easili
transmiss
agent
hospit
environ
studi
done
respiratori
sampl
young
children
sent
routin
hrsv
screen
clinic
virolog
laboratori
children
hrsv
infect
associ
shed
viabl
hrsv
oppos
hrsv
detect
rapid
antigen
detect
method
result
indic
children
true
diseas
shed
hrsv
clinic
featur
indistinguish
addit
viabl
hrsv
respiratori
virus
detect
pcr
addit
reiter
hrsv
import
pathogen
use
viabl
hrsv
recoveri
evid
current
infect
present
studi
provid
new
evid
associ
major
diseas
episod
attribut
hrsv
actual
replic
import
agent
